A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin
AffiliationUniversity of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
MetadataShow full item record
CitationJones R, Crabb S, Chester J, Elliott T, Huddart R, Birtle A, et al. A randomised Phase II trial of carboplatin and gemcitabine +/- vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. BJU Int. 2020.